These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 27040338)

  • 61. Ultimate fate of oncology drugs approved by the us food and drug administration without a randomized Trial.
    Tsimberidou AM; Braiteh F; Stewart DJ; Kurzrock R
    J Clin Oncol; 2009 Dec; 27(36):6243-50. PubMed ID: 19826112
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Characteristics of clinical trials to support approval of orphan vs nonorphan drugs for cancer.
    Kesselheim AS; Myers JA; Avorn J
    JAMA; 2011 Jun; 305(22):2320-6. PubMed ID: 21642684
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Pharmaceuticals and medical devices: medical devices. Issue brief.
    Health Policy Tracking Service, A Service of Thomson Reuters/West
    Issue Brief Health Policy Track Serv; 2011 Jan; ():1-24. PubMed ID: 21374838
    [No Abstract]   [Full Text] [Related]  

  • 64. Pharmaceuticals and Medical Devices: Medical Devices.
    Berry MD;
    Issue Brief Health Policy Track Serv; 2015 Dec; ():1-64. PubMed ID: 27116798
    [No Abstract]   [Full Text] [Related]  

  • 65. Medical devices; ear, nose and throat devices; reclassification of the endolymphatic shunt tube with valve. Final rule.
    Food and Drug Administration, HHS
    Fed Regist; 2002 Apr; 67(82):20893-4. PubMed ID: 11980454
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Japanese regulatory system for approval of off-label drug use: evaluation of safety and effectiveness in literature-based applications.
    Shimazawa R; Ikeda M
    Clin Ther; 2012 Oct; 34(10):2104-16. PubMed ID: 23036337
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Pharmaceuticals and medical devices: medical devices. Issue brief.
    Berry MD
    Issue Brief Health Policy Track Serv; 2012 Dec; ():1-35. PubMed ID: 23297445
    [No Abstract]   [Full Text] [Related]  

  • 68. Characteristics of drugs approved in Japan without conducting confirmatory clinical trials.
    Izuka S; Matsumaru N; Tsukamoto K
    J Clin Pharm Ther; 2021 Dec; 46(6):1582-1590. PubMed ID: 34250620
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Efficacy and safety concerns are important reasons why the FDA requires multiple reviews before approval of new drugs.
    Ross JS; Dzara K; Downing NS
    Health Aff (Millwood); 2015 Apr; 34(4):681-8. PubMed ID: 25847652
    [TBL] [Abstract][Full Text] [Related]  

  • 70. An example of US Food and Drug Administration device regulation: medical devices indicated for use in acute ischemic stroke.
    Peña C; Li K; Felten R; Ogden N; Melkerson M
    Stroke; 2007 Jun; 38(6):1988-92. PubMed ID: 17478744
    [TBL] [Abstract][Full Text] [Related]  

  • 71. FDA designations for therapeutics and their impact on drug development and regulatory review outcomes.
    Kesselheim AS; Darrow JJ
    Clin Pharmacol Ther; 2015 Jan; 97(1):29-36. PubMed ID: 25670381
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Orthopedic devices; effective data of requirement for premarket approval for hip joint metal/polymer or ceramic/polymer semiconstrained resurfacing cemented prosthesis. Final rule.
    Food and Drug Administration, HHS
    Fed Regist; 2004 Oct; 69(191):59132-4. PubMed ID: 15460583
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Medical devices; 30-day notices and 135-day PMA supplement review--FDA. Direct final rule; withdrawal.
    Fed Regist; 1998 Aug; 63(154):42699. PubMed ID: 10182563
    [TBL] [Abstract][Full Text] [Related]  

  • 74. [Industry regulation and its relationship to the rapid marketing of medical devices].
    Matsuoka A
    Kokuritsu Iyakuhin Shokuhin Eisei Kenkyusho Hokoku; 2012; (130):13-20. PubMed ID: 23243983
    [TBL] [Abstract][Full Text] [Related]  

  • 75. [Introduction of innovative high-risk medical devices in Europe: are clinical efficacy and safety guaranteed?].
    Stordeur S; Vinck I; Neyt M; Van Brabandt H; Hulstaert F
    Rev Epidemiol Sante Publique; 2013 Apr; 61(2):105-10. PubMed ID: 23477881
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Medical devices; classification for medical washer and medical washer-disinfector. Final rule.
    Food and Drug Administration, HHS
    Fed Regist; 2002 Nov; 67(221):69119-21. PubMed ID: 12437015
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Regulation of medical devices in radiology: current standards and future opportunities.
    Smith JJ
    Radiology; 2001 Feb; 218(2):329-35. PubMed ID: 11161144
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Lessons learned from independent central review.
    Ford R; Schwartz L; Dancey J; Dodd LE; Eisenhauer EA; Gwyther S; Rubinstein L; Sargent D; Shankar L; Therasse P; Verweij J
    Eur J Cancer; 2009 Jan; 45(2):268-74. PubMed ID: 19101138
    [TBL] [Abstract][Full Text] [Related]  

  • 79. [Pediatric drug development: ICH harmonized tripartite guideline E11 within the United States of America, the European Union, and Japan].
    Pflieger M; Bertram D
    Arch Pediatr; 2014 Oct; 21(10):1129-38. PubMed ID: 25175054
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Combination products regulation at the FDA.
    Lauritsen KJ; Nguyen T
    Clin Pharmacol Ther; 2009 May; 85(5):468-70. PubMed ID: 19381151
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.